DAFNA Capital Management LLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 26 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$139,000
-55.7%
53,525
-76.0%
0.12%
-57.2%
Q4 2016$314,000
-23.0%
223,3250.0%0.28%
-2.8%
Q3 2016$408,000
+13.3%
223,3250.0%0.28%
-0.4%
Q2 2016$360,000
+278.9%
223,325
+344.7%
0.28%
+247.6%
Q1 2016$95,000
-72.4%
50,214
-59.8%
0.08%
-71.8%
Q2 2015$344,000125,0000.29%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders